The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 9.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (10 analysts) rates it buy, with a mean price target of $49.
Bullish
BLSH · the NYSE · USD · Market cap $5.5B · 414 employees
Bullish, a global digital asset platform that provides market infrastructure and information services in United States.
PASS · Titan Ethical · score 70.0At the last full screen
2026-09-04
Screened 2026-09-04 · the tape above runs as of 21:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markup label.
Bullish holds its Markup at $36.00. The statistical read favours the buyers, held for 22 days.
| Phase | Markup |
| Quantitative state | The statistical read favours the buyers, held for 22 days |
| Price at the screen | $36.00 |
| Valuation | N/A trailing · 51.43 forward price to earnings |
| Values screen | PASS · score 70.0 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 9.30% | Below 33% | Interest-bearing debt is just 9.3% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 7.87% | Below 33% | Cash held in interest-bearing accounts and securities is 7.9% of assets, under the one-third limit. | Pass |
| Receivables | 0.00% | Below 49% | Money owed to the company is 0.0% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.00% | Below 5% | Only 0.0% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Our framework reads OVERVALUED: it trades above our $28.60 fair value estimate, weak competitive moat, 68.80% revenue growth.
Fair value range in USD, drawn from the 2026-09-04 screen. The gold marker is the market price at the same screen. The price runs 20.6% above the base estimate.
Third-party analyst targets: 9 covering, consensus Buy. The average target sits +8% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-04 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsCrypto Exchange Growing Fast But Still Unprofitable
Picture a trading venue built for crypto flows that must still prove it can turn activity into steady cash. Bullish runs a spot and derivatives exchange with a central order book and automated tools, yet it posts zero profit margins and a negative 45 percent return on equity. Revenue is expanding at 66 percent, which draws analyst attention, but the shares already trade above our fair value estimate with a forward multiple of 25.7 times.
We pass because the combination of weak competitive protection and absent bottom-line delivery outweighs the growth headline. The market prices in optimism that has not yet arrived in reported earnings, and the opportunity rating flags the stock as overvalued at current levels. Ethical screens clear, yet that alone does not fix the missing profits or thin moat.
Risk sits in execution and crypto volatility, where revenue can swing sharply and competition from larger platforms remains intense. Negative returns and zero margins signal the business has yet to clear the basic test of durable cash generation. Analysis, not advice.
| Forward P/E | 51.4xcheap for a company growing this fast |
| EPS, trailing | -10.00 |
| EPS, forward | 0.70 |
| Revenue growth | +68.8%growing very fast |
| Profit margin | 0.0%currently unprofitable |
| Return on equity | -57.1%not currently earning a positive return on equity |
| FCF yield | -7.49% |
| Debt to equity | 0.21minimal debt: a conservative balance sheet |
| Current ratio | 23.53comfortably covers its short-term bills |
| Short interest, float | 0.17% |
| 52-week range | 20.55 - 74.98 |
| Moat | WEAK |
| Market cap | $5.5B |
| Employees | 414 |
The risks · The things to watch: its business and earnings are exposed to Cayman Islands and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeBLSH trades on the NYSE (the company is based in Cayman Islands). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 17.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (10 analysts) rates it buy, with a mean price target of $49.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (10 analysts) rates it buy, with a mean price target of $49.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $44.03 | -39.3% | · | $607 | -39.3% |
| 2 months | $36.23 | -26.3% | · | $737 | -26.3% |
| 3 months | $36.24 | -26.3% | · | $737 | -26.3% |
| 6 months | $45.38 | -41.1% | · | $589 | -41.1% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever BLSH does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.